In Germany, in the second half of the nineties, a dynamic development of commercial biotechnology took place, undertaken by a considerable number of new firms. The following article deals with the foundation of biotechnological firms in the BioRegion Rhine-Neckar Triangle (with the center in Heidelberg). For a long time, the development of biotechnology in Germany and in the Rhine-Neckar Triangle was hindered by institutional barriers. The main reasons were the narrowing of company strategies of big chemical and pharmaceutical firms, the low impulses to found biotechnology companies out of academic research, the institutional surroundings not aligned to the needs of biotechnology (e.g. no venture capital market) and finally government restraints concerning the specific and particularly regional concentrated support of biotechnology. These particularities are also reflected by the structure of the population of young companies in the Rhine-Neckar Triangle. The main emphasis of biotechnology firms is placed on technological services (research on demand) and platform technologies, different sub-areas of therapeutics research (pharmaceutical basic materials, finding active substances), on the production for the diagnostics industry and on bioinformatics. These companies do not co-operate much, national and international relations predominate. Only a few scientists of regional research institutions want to found a biotechnology firm, although the region seems to attract a certain number of company founders from other regions.
Small Business Economics – Springer Journals
Published: Oct 3, 2004
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera